Yu-Juan Zhou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yu-Juan Zhou

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 11, 2020

Different findings of morphological changes and functional decline in the vestibule and the semicircular canal in ipsilateral delayed endolymphatic hydropsJing Yu, Yu-Juan Zhou, Xin-Da Xu, et al.

Plos One|July 28, 2018

In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cellsZong-Jun-Lin Liu, Yu-Juan Zhou, Rui-Lin Ding, et al.

Pathology Oncology Research : POR|November 4, 2022

Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell CarcinomaQiang Huang, Yu-Jie Shen, Chi-Yao Hsueh, et al.

Med (New York, N.Y.)|February 20, 2026

Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trialFei Han, Xing Lv, Yu-Juan Zhou, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025

GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 11, 2020

Different findings of morphological changes and functional decline in the vestibule and the semicircular canal in ipsilateral delayed endolymphatic hydropsJing Yu, Yu-Juan Zhou, Xin-Da Xu, et al.

Plos One|July 28, 2018

In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cellsZong-Jun-Lin Liu, Yu-Juan Zhou, Rui-Lin Ding, et al.

Pathology Oncology Research : POR|November 4, 2022

Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell CarcinomaQiang Huang, Yu-Jie Shen, Chi-Yao Hsueh, et al.

Med (New York, N.Y.)|February 20, 2026

Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trialFei Han, Xing Lv, Yu-Juan Zhou, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025

GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.

Pageof 2